Accredo Health Group, Inc., a leading specialty pharmacy based in the United States, has been at the forefront of healthcare since its establishment in 1996. With its headquarters in Memphis, Tennessee, Accredo operates across various regions, providing essential services to patients with complex health conditions. Specialising in the management of chronic and rare diseases, Accredo offers a range of unique products and services, including medication management, patient support, and clinical care. The company is recognised for its commitment to personalised care, ensuring that patients receive tailored treatment plans that enhance their health outcomes. Accredo's market position is bolstered by its innovative approach and dedication to improving patient experiences, making it a trusted partner in the specialty pharmacy industry.
How does Accredo Health Group, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Accredo Health Group, Inc.'s score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Accredo Health Group, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of The Cigna Group, any climate commitments or emissions data would be cascaded from this parent organisation. While there are no specific reduction targets or achievements reported for Accredo Health Group, it is important to note that the climate initiatives and targets from The Cigna Group apply at this level. The Cigna Group has established various climate commitments, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which aim to reduce emissions across their operations. As Accredo Health Group inherits these commitments, it aligns with the broader sustainability goals set by The Cigna Group, although specific metrics or targets for Accredo itself are not detailed. The absence of direct emissions data highlights the need for ongoing transparency and commitment to climate action within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 11,737,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 
| Scope 2 | 75,874,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 
| Scope 3 | 25,072,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000,000 | 000,000 | 
Accredo Health Group, Inc.'s Scope 3 emissions, which decreased by 100% last year and decreased by approximately 98% since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Employee Commuting" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Accredo Health Group, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.